Methyl N-[(1S)-1-[[(2S)-2-[5-[6-[2-[(2S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-2-pyrrolidinyl]-1H-benzimidazol-6-y l]-2-naphthalenyl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]-2-methylpropyl]carbamate dihydrochloride
CAS: 1303533-81-4
Ref. 3D-DCC53381
1g | 1.121,00 € | ||
50mg | 192,00 € | ||
100mg | 284,00 € | ||
250mg | 461,00 € | ||
500mg | 737,00 € |
Información del producto
- Ravidasvir dihydrochloride
Methyl N-[(1S)-1-[[(2S)-2-[5-[6-[2-[(2S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-2-pyrrolidinyl]-1H-benzimidazol-6-y l]-2-naphthalenyl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]-2-methylpropyl]carbamate dihydrochloride is a matrix effect medicine that belongs to the group of drugs used in the treatment of HIV infection. It has been shown to be effective against PDL1, which is often expressed by tumors and is associated with poor prognosis. This drug has also been shown to have antiviral activity against hepatitis C virus (HCV). The pharmacokinetic properties of methyl N-[(
Propiedades químicas
Consulta técnica sobre: 3D-DCC53381 Methyl N-[(1S)-1-[[(2S)-2-[5-[6-[2-[(2S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-2-pyrrolidinyl]-1H-benzimidazol-6-y l]-2-naphthalenyl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]-2-methylpropyl]carbamate dihydrochloride
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.